thetaiotaomicron are capable of suppressing GLP-1 levels and, most importantly, locomotion in an antibiotic-treated mouse model, we first tested locomotor activity in ampicillin-treated mice following the previously described procedure (Fig
After 4-6 weeks of confirmed tolerance, additional products can be introduced gradually
At that concentration, a 250 mcg dose equals exactly 0.1mL, or 10 units on a U-100 syringe
Because GLP-1s can have gastrointestinal (GI) side effects, such as nausea, vomiting, irregular bowel movements, bloating, etc., working with a qualified dietitian and nutritionist can also assist people using them learn how to manage these symptoms via dietary interventions
It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction